| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |